Stopping treatment after having breast cancer can be both liberating and terrifying. While it may be nice to end the treatments and medications and the side effects and complications that can go with them, it can also be scary to leave the almost constant care of doctors and the treatments that got you to the point where you are now. However, there is an increasing demand for continued care for survivors, not just patients, and oncologists are stepping up to take on this responsibility.
Hundreds of thousands of breast cancer survivors take an aromatase inhibitor (AI) – Arimidex, Femara, or Aromasin – as part of a long-term effort to reduce the risk their cancer will come back. But these drugs are still so new, long-term data that would determine the optimal duration of treatment just isn’t available. Should you…